메뉴 건너뛰기




Volumn 51, Issue 1-2, 2002, Pages 31-71

Progress report on new antiepileptic drugs: A summary of the Sixth Eilat Conference (EILAT VI)

Author keywords

Antiepileptic drugs; Clinical trials; Conference; Drug development; Epilepsy; Pharmacology

Indexed keywords

ANTICONVULSIVE AGENT; CARABERSAT; CARBAMAZEPINE; CONANTOKIN G; DEPAKOTE DR; DIGOXIN; DIZOCILPINE; ETIRACETAM; FOSPHENYTOIN SODIUM; GABAPENTIN; HARKOSERIDE; IFENPRODIL; LAMOTRIGINE; METFORMIN; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENYTOIN; PLACEBO; PREGABALIN; RETIGABINE; SAFINAMIDE; SPD 421; TALAMPANEL; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VALROCEMIDE; VIGABATRIN; WARFARIN; ZONISAMIDE;

EID: 0036752811     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(02)00106-7     Document Type: Article
Times cited : (185)

References (136)
  • 1
    • 4243382436 scopus 로고    scopus 로고
    • Evaluation of lamotrigine pharmacokinetics during conversion to monotherapy: Time course of deinduction from carbamazepine or phenytoin
    • Anderson G.D., Gila B.E., Gillian F., Messenheimer J. Evaluation of lamotrigine pharmacokinetics during conversion to monotherapy: time course of deinduction from carbamazepine or phenytoin. Neurology. 56 (Suppl. 3):2001;A330-A331.
    • (2001) Neurology , vol.56 , Issue.SUPPL. 3
    • Anderson, G.D.1    Gila, B.E.2    Gillian, F.3    Messenheimer, J.4
  • 2
    • 0002883913 scopus 로고    scopus 로고
    • Topiramate affects the ability of cAMP-activated protein kinase to phosphorylate glutamate receptors activated by kainate
    • Angehagen M., Shank R., Hansson E., Ronnback L., Ben-Menachem E. Topiramate affects the ability of cAMP-activated protein kinase to phosphorylate glutamate receptors activated by kainate. Epilepsia. 42 (Suppl. 7):2001;10.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 10
    • Angehagen, M.1    Shank, R.2    Hansson, E.3    Ronnback, L.4    Ben-Menachem, E.5
  • 3
    • 0034015285 scopus 로고    scopus 로고
    • Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death
    • Annegers J.F., Coan S.P., Hauser W.A., Leestma J. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death. Epilepsia. 41:2000;549-553.
    • (2000) Epilepsia , vol.41 , pp. 549-553
    • Annegers, J.F.1    Coan, S.P.2    Hauser, W.A.3    Leestma, J.4
  • 4
    • 0032800766 scopus 로고    scopus 로고
    • Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multicenter, double-blind, placebo-controlled study
    • The Gabapentin Pediatric Study Group, Appleton R., Fichtner K., LaMoreaux L., Alexander J., Halsall G., Murray G., Garofalo E. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicenter, double-blind, placebo-controlled study. Epilepsia. 40:1999;1147-1154.
    • (1999) Epilepsia , vol.40 , pp. 1147-1154
    • Appleton, R.1    Fichtner, K.2    LaMoreaux, L.3    Alexander, J.4    Halsall, G.5    Murray, G.6    Garofalo, E.7
  • 5
    • 0032703827 scopus 로고    scopus 로고
    • Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms
    • Appleton R.E., Peters A.C.B., Mumford J.P., Shaw D.E. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 40:1999;1627-1633.
    • (1999) Epilepsia , vol.40 , pp. 1627-1633
    • Appleton, R.E.1    Peters, A.C.B.2    Mumford, J.P.3    Shaw, D.E.4
  • 6
    • 0034535858 scopus 로고    scopus 로고
    • Oxcarbazepine: Placebo-controlled, dose-ranging trial in refractory partial epilepsy
    • Barcs G., Walker E.B., Elger C.E., et al. Oxcarbazepine: placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia. 42:2000;1597-1607.
    • (2000) Epilepsia , vol.42 , pp. 1597-1607
    • Barcs, G.1    Walker, E.B.2    Elger, C.E.3
  • 7
    • 0022567305 scopus 로고
    • The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy
    • Bazan N.G., Birkle D.L., Tang W., Reddy T.S. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy. Adv. Neurol. 44:1986;879-902.
    • (1986) Adv. Neurol. , vol.44 , pp. 879-902
    • Bazan, N.G.1    Birkle, D.L.2    Tang, W.3    Reddy, T.S.4
  • 8
    • 0034777483 scopus 로고    scopus 로고
    • Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats
    • Belayev L., Alonso O.F., Liu Y., Chappell A.S., Zhao W., Ginsberg M.D., Busto R. Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats. J. Neurotrauma. 18:2001;1031-1038.
    • (2001) J. Neurotrauma , vol.18 , pp. 1031-1038
    • Belayev, L.1    Alonso, O.F.2    Liu, Y.3    Chappell, A.S.4    Zhao, W.5    Ginsberg, M.D.6    Busto, R.7
  • 9
    • 0033775210 scopus 로고    scopus 로고
    • Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy
    • The European Levetiracetam Study Group, Ben-Menachem E., Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia. 41:2000;1276-1283.
    • (2000) Epilepsia , vol.41 , pp. 1276-1283
    • Ben-Menachem, E.1    Falter, U.2
  • 10
    • 0011106890 scopus 로고    scopus 로고
    • Predictors of weight loss in patients with epilepsy treated with topiramate
    • Ben-Menachem E., Smith U., Hellstrom K., Stagge A. Predictors of weight loss in patients with epilepsy treated with topiramate. Epilepsia. 42 (Suppl. 7):2001;252.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 252
    • Ben-Menachem, E.1    Smith, U.2    Hellstrom, K.3    Stagge, A.4
  • 11
    • 0011106891 scopus 로고    scopus 로고
    • Treatment of epilepsy with tiagabine as add-on antiepileptic drug in patients with refractory seizures: Experiences in 574 patients
    • Bergmann A., Bauer J., Stodieck S. Treatment of epilepsy with tiagabine as add-on antiepileptic drug in patients with refractory seizures: experiences in 574 patients. Epilepsia. 41 (Suppl. 6):2000;40.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL. 6 , pp. 40
    • Bergmann, A.1    Bauer, J.2    Stodieck, S.3
  • 12
    • 0034720870 scopus 로고    scopus 로고
    • Oxcarbazepine monotherapy for partial-onset seizures: A multicenter, double-blind, clinical trial
    • Beydoun A., Sachdeo R.C., Rosenfeld W.E., et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology. 54:2000;2245-2251.
    • (2000) Neurology , vol.54 , pp. 2245-2251
    • Beydoun, A.1    Sachdeo, R.C.2    Rosenfeld, W.E.3
  • 13
    • 0002205776 scopus 로고    scopus 로고
    • Long-term safety and efficacy of oxcarbazepine in patienst with refractory partial epilepsy
    • Beydoun A., Sachdeo R.C., Rosenfeld W.E., D'Souza J. Long-term safety and efficacy of oxcarbazepine in patienst with refractory partial epilepsy. Epilepsia. 42 (Suppl. 7)##:2001;176-177.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 176-177
    • Beydoun, A.1    Sachdeo, R.C.2    Rosenfeld, W.E.3    D'Souza, J.4
  • 14
    • 0002472770 scopus 로고    scopus 로고
    • Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia
    • Beydoun A., Schmidt D., D-Souza J. Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia. J. Pain. 3 (Suppl. 1):2002;38.
    • (2002) J. Pain , vol.3 , Issue.SUPPL. 1 , pp. 38
    • Beydoun, A.1    Schmidt, D.2    D-Souza, J.3
  • 18
    • 0030805745 scopus 로고    scopus 로고
    • A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
    • Bill P.A., Vigonius U., Pohlmann H., et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 27:1997;195-204.
    • (1997) Epilepsy Res. , vol.27 , pp. 195-204
    • Bill, P.A.1    Vigonius, U.2    Pohlmann, H.3
  • 19
    • 0034904004 scopus 로고    scopus 로고
    • High strength stimulation of the vagus nerve in awake humans: A lack of cardiorespiratory effects
    • Binks A.P., Paydarfar D., Schachter S.C., et al. High strength stimulation of the vagus nerve in awake humans: a lack of cardiorespiratory effects. Respir. Physiol. 127:2001;125-133.
    • (2001) Respir. Physiol. , vol.127 , pp. 125-133
    • Binks, A.P.1    Paydarfar, D.2    Schachter, S.C.3
  • 20
    • 0035936604 scopus 로고    scopus 로고
    • Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy
    • Biton V., Mirza W., Montouris G., Vuong A., Hammer A.E., Barret P.S. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 56:2001;172-177.
    • (2001) Neurology , vol.56 , pp. 172-177
    • Biton, V.1    Mirza, W.2    Montouris, G.3    Vuong, A.4    Hammer, A.E.5    Barret, P.S.6
  • 22
    • 0030849279 scopus 로고    scopus 로고
    • The disposition of valproyl glycinamide and valproyl glycine in rats
    • Blotnik S., Bergman F., Bialer M. The disposition of valproyl glycinamide and valproyl glycine in rats. Pharm. Res. 14:1997;873-878.
    • (1997) Pharm. Res. , vol.14 , pp. 873-878
    • Blotnik, S.1    Bergman, F.2    Bialer, M.3
  • 24
    • 0000256151 scopus 로고    scopus 로고
    • Gabapentin versus lamotrigine monotherapy: A double-blind comparison
    • The 945-212 Study Group, Brodie M.J., Anhut H., Murray G., Maton S. Gabapentin versus lamotrigine monotherapy: a double-blind comparison. Epilepsia. 41 (Suppl. 6):2000;138-139.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL. 6 , pp. 138-139
    • Brodie, M.J.1    Anhut, H.2    Murray, G.3    Maton, S.4
  • 26
    • 0010958643 scopus 로고    scopus 로고
    • An open-label, prospective trail of oxcarbazepine in the treatment of painful diabetic neuropathy
    • Carrazana E., Beydoun A., Kobetz S., Constantine S. An open-label, prospective trail of oxcarbazepine in the treatment of painful diabetic neuropathy. J. Pain. 3 (Suppl. 1):2002;28.
    • (2002) J. Pain , vol.3 , Issue.SUPPL. 1 , pp. 28
    • Carrazana, E.1    Beydoun, A.2    Kobetz, S.3    Constantine, S.4
  • 27
    • 0343247768 scopus 로고    scopus 로고
    • A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
    • Christe W., Kramer G., Vigonius U., et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res. 26:1997;451-460.
    • (1997) Epilepsy Res. , vol.26 , pp. 451-460
    • Christe, W.1    Kramer, G.2    Vigonius, U.3
  • 28
    • 0034871011 scopus 로고    scopus 로고
    • A systematic review of the associations between dose regimens and medication compliance
    • Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 23:2001;1296-1310.
    • (2001) Clin. Ther. , vol.23 , pp. 1296-1310
    • Claxton, A.J.1    Cramer, J.2    Pierce, C.3
  • 29
    • 0011106893 scopus 로고    scopus 로고
    • Depakote CR: Biopharmaceutical and pharmacokinetic studies of a new formulation for once daily dosing
    • Collins S.D., Cavanaugh J., Elisseou M., Lamm J., Sommerville K.W. Depakote CR: biopharmaceutical and pharmacokinetic studies of a new formulation for once daily dosing. Neurology. 50 (Suppl. 4):1998;50.
    • (1998) Neurology , vol.50 , Issue.SUPPL. 4 , pp. 50
    • Collins, S.D.1    Cavanaugh, J.2    Elisseou, M.3    Lamm, J.4    Sommerville, K.W.5
  • 30
    • 0032561315 scopus 로고    scopus 로고
    • LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs
    • Czuczwar S.J., Swiader M., Kuzniar H., Gasior M., Kleinrok Z. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs. Eur. J. Pharmacol. 359:1998;103-109.
    • (1998) Eur. J. Pharmacol. , vol.359 , pp. 103-109
    • Czuczwar, S.J.1    Swiader, M.2    Kuzniar, H.3    Gasior, M.4    Kleinrok, Z.5
  • 31
    • 0024494368 scopus 로고
    • A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy
    • Dam M., Ekberg R., Løyning Y., Waltimo O., Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res. 3:1989;70-76.
    • (1989) Epilepsy Res. , vol.3 , pp. 70-76
    • Dam, M.1    Ekberg, R.2    Løyning, Y.3    Waltimo, O.4    Jakobsen, K.5
  • 32
    • 0033811085 scopus 로고    scopus 로고
    • Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures
    • DeGiorgio C.M., Schachter S.C., Handforth A., et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. 41:2000;1195-1200.
    • (2000) Epilepsia , vol.41 , pp. 1195-1200
    • DeGiorgio, C.M.1    Schachter, S.C.2    Handforth, A.3
  • 33
    • 4244078186 scopus 로고    scopus 로고
    • Topiramate improves glucose tolerance and may improve insulin sensitivity in animal models of type 2 diabetes mellitus
    • Demarest K., Conway B., Osborne M., Chen X. Topiramate improves glucose tolerance and may improve insulin sensitivity in animal models of type 2 diabetes mellitus. Diabetes. 50 (Suppl. 2):2001;A302.
    • (2001) Diabetes , vol.50 , Issue.SUPPL. 2
    • Demarest, K.1    Conway, B.2    Osborne, M.3    Chen, X.4
  • 35
    • 0033851790 scopus 로고    scopus 로고
    • Conantokin G is an NR2B selective competitive antagonist of NMDA receptors
    • Donevan S.D., McCabe R.T. Conantokin G is an NR2B selective competitive antagonist of NMDA receptors. Mol. Pharmacol. 58:2000;614-623.
    • (2000) Mol. Pharmacol. , vol.58 , pp. 614-623
    • Donevan, S.D.1    McCabe, R.T.2
  • 36
    • 0000192527 scopus 로고    scopus 로고
    • An open-label trial of tiagabine for migraine prophylaxis
    • Drake M.E., Kay A.M., Knapp M.S., Greathouse N.J. An open-label trial of tiagabine for migraine prophylaxis. Headache. 39:1999;352.
    • (1999) Headache , vol.39 , pp. 352
    • Drake, M.E.1    Kay, A.M.2    Knapp, M.S.3    Greathouse, N.J.4
  • 38
    • 0002060457 scopus 로고    scopus 로고
    • Lamotrigine monotherapy improves depressive symptoms in epilepsy: A double-blind comparison with valproate
    • Edwards K.R., Sackellares J.C., Vuong A., Hammer A.E., Barrett P.S. Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav. 2:2001;28-36.
    • (2001) Epilepsy Behav. , vol.2 , pp. 28-36
    • Edwards, K.R.1    Sackellares, J.C.2    Vuong, A.3    Hammer, A.E.4    Barrett, P.S.5
  • 40
    • 0020562267 scopus 로고
    • Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report
    • Emrich H.M., Altmann H., Dose M., et al. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Pharmacol. Biochem. Behav. 19:1983;369-372.
    • (1983) Pharmacol. Biochem. Behav. , vol.19 , pp. 369-372
    • Emrich, H.M.1    Altmann, H.2    Dose, M.3
  • 42
    • 0033958716 scopus 로고    scopus 로고
    • Acute behavioural and EEG effects of NW-1015 on electrically induced afterdischarge in conscious monkeys
    • Fariello R.G., Maj R., Marrari P., Salvati P. Acute behavioural and EEG effects of NW-1015 on electrically induced afterdischarge in conscious monkeys. Epilepsy Res. 39:2000;37-46.
    • (2000) Epilepsy Res. , vol.39 , pp. 37-46
    • Fariello, R.G.1    Maj, R.2    Marrari, P.3    Salvati, P.4
  • 43
    • 0035960602 scopus 로고    scopus 로고
    • Randomized controlled trial of zonisamide for the treatment vof refartory partial-onset seizures
    • Faught E., Ayala R., Monotouris G.G., Leppik I.E. Randomized controlled trial of zonisamide for the treatment vof refartory partial-onset seizures. Neurology. 57:2001;1774-1779.
    • (2001) Neurology , vol.57 , pp. 1774-1779
    • Faught, E.1    Ayala, R.2    Monotouris, G.G.3    Leppik, I.E.4
  • 45
    • 0030947362 scopus 로고    scopus 로고
    • Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes
    • Fischer J.H., Cwik M.J., Luer M.S., Sibley C.B., Deyo K.L. Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes. Ann. Pharmacother. 31:1997;553-559.
    • (1997) Ann. Pharmacother. , vol.31 , pp. 553-559
    • Fischer, J.H.1    Cwik, M.J.2    Luer, M.S.3    Sibley, C.B.4    Deyo, K.L.5
  • 46
    • 0034876918 scopus 로고    scopus 로고
    • Left vagus nerve stimulation with the neurocybernetic prosthesis has complex effects on heart rate and on its variability in humans
    • Frei M.G., Osorio I. Left vagus nerve stimulation with the neurocybernetic prosthesis has complex effects on heart rate and on its variability in humans. Epilepsia. 42:2001;1007-1016.
    • (2001) Epilepsia , vol.42 , pp. 1007-1016
    • Frei, M.G.1    Osorio, I.2
  • 49
    • 0002533396 scopus 로고    scopus 로고
    • Lamotrigine pharmacokinetics in the presence of low-dose valproic acid (VPA) and during conversion to monotherapy
    • Gidal B.E., Nanry K.P., Sheth R.D., Parnell J., Barrett P., Hutson P.R. Lamotrigine pharmacokinetics in the presence of low-dose valproic acid (VPA) and during conversion to monotherapy. Epilepsia. 42 (Suppl. 7):2001;89.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 89
    • Gidal, B.E.1    Nanry, K.P.2    Sheth, R.D.3    Parnell, J.4    Barrett, P.5    Hutson, P.R.6
  • 50
    • 18844471793 scopus 로고    scopus 로고
    • Adjunctive therapy with oxcarbazepine in children with partial seizures
    • Glauser T.A., Nigro M., Sachdeo R.C., et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology. 54:2000;2237-2244.
    • (2000) Neurology , vol.54 , pp. 2237-2244
    • Glauser, T.A.1    Nigro, M.2    Sachdeo, R.C.3
  • 51
    • 0000153970 scopus 로고    scopus 로고
    • Long-term efficacy and safety of adjunctive-oxcarbazepine therapy in children with partial onset seizures
    • Glauser T.A., Nigro M., Sachdeo R.C., Beydoun A., D'Souza J. Long-term efficacy and safety of adjunctive-oxcarbazepine therapy in children with partial onset seizures. Epilepsia. 42 (Suppl. 7):2001;54.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 54
    • Glauser, T.A.1    Nigro, M.2    Sachdeo, R.C.3    Beydoun, A.4    D'Souza, J.5
  • 52
    • 0011146974 scopus 로고    scopus 로고
    • Efficacy of 200 mg/day topiramate in treatment-resistant partial seizures when added to an enzyme-inducing antiepileptic drug
    • Guberman A., Neto W., Gassman-Mayer C. Efficacy of 200 mg/day topiramate in treatment-resistant partial seizures when added to an enzyme-inducing antiepileptic drug. Epilepsia. 42 (Suppl. 7):2001;179.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 179
    • Guberman, A.1    Neto, W.2    Gassman-Mayer, C.3
  • 53
    • 0030796901 scopus 로고    scopus 로고
    • A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
    • Guerreiro M.M., Vigonius U., Pohlmann H., et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 27:1997;205-213.
    • (1997) Epilepsy Res. , vol.27 , pp. 205-213
    • Guerreiro, M.M.1    Vigonius, U.2    Pohlmann, H.3
  • 54
    • 0029020746 scopus 로고
    • Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine
    • Hadad S., Bialer M. Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine. Pharm. Res. 12:1995;1160-1163.
    • (1995) Pharm. Res. , vol.12 , pp. 1160-1163
    • Hadad, S.1    Bialer, M.2
  • 55
    • 0037161272 scopus 로고    scopus 로고
    • Field-specific visual-evoked potentials: Identifying field defects in vigabatrin-treated children
    • Harding G.F., Spencer E.L., Wild J.M., Conway M., Bohn R.L. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children. Neurology. 58:2002;1261-1265.
    • (2002) Neurology , vol.58 , pp. 1261-1265
    • Harding, G.F.1    Spencer, E.L.2    Wild, J.M.3    Conway, M.4    Bohn, R.L.5
  • 56
    • 0033837868 scopus 로고    scopus 로고
    • Separating the retinal electrophysiologic effects of vigabatrin: Treatment versus field loss
    • Harding G.F., Wild J.M., Robertson K.A., Rietbrock S., Martinez C. Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology. 55:2000;347-352.
    • (2000) Neurology , vol.55 , pp. 347-352
    • Harding, G.F.1    Wild, J.M.2    Robertson, K.A.3    Rietbrock, S.4    Martinez, C.5
  • 59
    • 0000382615 scopus 로고    scopus 로고
    • Effects of age and gender on the pharmacokinetics of retigabine
    • Hermann R., Ferron G.M., Knebel N., Paul J., Richards L.S., Ruus P. Effects of age and gender on the pharmacokinetics of retigabine. Epilepsia. 41 (Suppl. 7):2000;115.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL. 7 , pp. 115
    • Hermann, R.1    Ferron, G.M.2    Knebel, N.3    Paul, J.4    Richards, L.S.5    Ruus, P.6
  • 62
    • 0032809111 scopus 로고    scopus 로고
    • Benign neonatal familial convultions: A model of idiopathic epilepsy
    • Hirsch E., De Saint-Martin A., Marescaux C. Benign neonatal familial convultions: a model of idiopathic epilepsy. Rev. Neurol. 155:1999;463-467.
    • (1999) Rev. Neurol. , vol.155 , pp. 463-467
    • Hirsch, E.1    De Saint-Martin, A.2    Marescaux, C.3
  • 63
    • 0034793279 scopus 로고    scopus 로고
    • Highlights of CNS research at IDR: 2,3-benzodiazepines
    • Horváth K. Highlights of CNS research at IDR: 2,3-benzodiazepines. Pharmazie. 56 (Suppl. 1):2001;S56-S61.
    • (2001) Pharmazie , vol.56 , Issue.SUPPL. 1
    • Horváth, K.1
  • 65
    • 0034844676 scopus 로고    scopus 로고
    • Anticonvulsant profile of valrocemide (TV1901): A new antiepileptic drug
    • Isoherranen N., Woodhead J.H., White H.S., Bialer M. Anticonvulsant profile of valrocemide (TV1901): a new antiepileptic drug. Epilepsia. 42:2001;831-836.
    • (2001) Epilepsia , vol.42 , pp. 831-836
    • Isoherranen, N.1    Woodhead, J.H.2    White, H.S.3    Bialer, M.4
  • 66
    • 0035069775 scopus 로고    scopus 로고
    • Visual field defects with vigabatrin: Epidemiology and therapeutic implications
    • Kalviainen R., Nousianen I. Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs. 15:2001;217-230.
    • (2001) CNS Drugs , vol.15 , pp. 217-230
    • Kalviainen, R.1    Nousianen, I.2
  • 67
    • 0002357713 scopus 로고    scopus 로고
    • A study of visual fields in patients receiving tiagabine as monotherapy versus carbamazepine or lamotrigine monotherapy
    • Kälviäinen R., Hache J.-C., Renault-Djouadi J. A study of visual fields in patients receiving tiagabine as monotherapy versus carbamazepine or lamotrigine monotherapy. Epilepsia. 42 (Suppl. 7):2001;256.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 256
    • Kälviäinen, R.1    Hache, J.-C.2    Renault-Djouadi, J.3
  • 68
    • 0011088654 scopus 로고    scopus 로고
    • Treatment of painful sensory neuropathy with tiagabine hydrochloride
    • Rio Grande, Puerto Rico, October 27-29
    • Kanard, R., et al., 2000. Treatment of painful sensory neuropathy with tiagabine hydrochloride. Poster presented at International Symposium on the Autonomic Nervous System, Rio Grande, Puerto Rico, October 27-29.
    • (2000) International Symposium on the Autonomic Nervous System
    • Kanard, R.1
  • 70
    • 0011117853 scopus 로고    scopus 로고
    • Tiagabine (Gabitril) in the management of painful diabetic polyneuropathy
    • Fort Lauderdale, FL, October 21-22
    • Kirby, L.C., et al., 1999. Tiagabine (Gabitril) in the management of painful diabetic polyneuropathy. Poster presented at American Pain Society; Fort Lauderdale, FL, October 21-22.
    • (1999) American Pain Society
    • Kirby, L.C.1
  • 71
    • 0002202079 scopus 로고    scopus 로고
    • Fosphenytoin: Pharmacokinetics and administration
    • Knapp L.E., Kugler A.R., Eldon M.A. Fosphenytoin: pharmacokinetics and administration. Emerg. Med. 28 (Suppl. 4):1996;9-16.
    • (1996) Emerg. Med. , vol.28 , Issue.SUPPL. 4 , pp. 9-16
    • Knapp, L.E.1    Kugler, A.R.2    Eldon, M.A.3
  • 72
    • 0034090891 scopus 로고    scopus 로고
    • AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys
    • Konitsiotis S., Blanchet P.J., Verhagen L., Lamers E., Chase T.N. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology. 54:2000;1589-1595.
    • (2000) Neurology , vol.54 , pp. 1589-1595
    • Konitsiotis, S.1    Blanchet, P.J.2    Verhagen, L.3    Lamers, E.4    Chase, T.N.5
  • 73
    • 0001128158 scopus 로고    scopus 로고
    • EEG changes with vagus nerve stimulation and clinical application of these changes to determine optimum stimulation parameters
    • Koo B.K., Ham S.D., Canady A., Sood S. EEG changes with vagus nerve stimulation and clinical application of these changes to determine optimum stimulation parameters. Epilepsia. 41 (Suppl. 7):2000;226.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL. 7 , pp. 226
    • Koo, B.K.1    Ham, S.D.2    Canady, A.3    Sood, S.4
  • 74
    • 0011145917 scopus 로고    scopus 로고
    • Levetiracetam in elderly patients with epilepsy
    • Krämer G., Edrich P. Levetiracetam in elderly patients with epilepsy. Epilepsia. 42 (Suppl. 7):2001;142.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 142
    • Krämer, G.1    Edrich, P.2
  • 75
    • 0035954353 scopus 로고    scopus 로고
    • Long-term continuation of levetiracetam in patients with refractory epilepsy
    • Krakow K., Walker M., Otoul C., Sander J.W.A.S. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology. 56:2001;1772-1774.
    • (2001) Neurology , vol.56 , pp. 1772-1774
    • Krakow, K.1    Walker, M.2    Otoul, C.3    Sander, J.W.A.S.4
  • 76
    • 0033629142 scopus 로고    scopus 로고
    • Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitroproionic acid: Evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy
    • Lee W.T., Shen Y.Z., Chang C. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitroproionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Neuroscience. 95:2000;89-95.
    • (2000) Neuroscience , vol.95 , pp. 89-95
    • Lee, W.T.1    Shen, Y.Z.2    Chang, C.3
  • 77
    • 0034059343 scopus 로고    scopus 로고
    • Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders
    • Lees G.J. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs. 59:2000;33-78.
    • (2000) Drugs , vol.59 , pp. 33-78
    • Lees, G.J.1
  • 78
    • 0028129087 scopus 로고
    • Gabapentin as add-on therapy for refractory partial epilepsy: Results of five placebo-controlled trials
    • Leiderman D.B. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials. Epilepsia. 35:1994;74-76.
    • (1994) Epilepsia , vol.35 , pp. 74-76
    • Leiderman, D.B.1
  • 79
    • 0011087189 scopus 로고    scopus 로고
    • An early view of results from the K.E.E.P.E.R. trial: A phase iv community-based clinical trial investigating levetiracetam as add-on therapy in partial-onset seizures
    • Leppik I.E., French J.A., Ferrendelli J.A., Katos M.G., Morrell M.J. An early view of results from the K.E.E.P.E.R. trial: a phase iv community-based clinical trial investigating levetiracetam as add-on therapy in partial-onset seizures. Epilepsia. 42 (Suppl. 7):2001;154.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 154
    • Leppik, I.E.1    French, J.A.2    Ferrendelli, J.A.3    Katos, M.G.4    Morrell, M.J.5
  • 80
    • 0029070492 scopus 로고
    • Anticonvulsant and antiepileptogenic effect of L-deprenyl (selegiline) in the kindling model of epilepsy
    • Loscher W., Honack D. Anticonvulsant and antiepileptogenic effect of L-deprenyl (selegiline) in the kindling model of epilepsy. J. Pharmacol. Exp. Ther. 274:1995;307-314.
    • (1995) J. Pharmacol. Exp. Ther. , vol.274 , pp. 307-314
    • Loscher, W.1    Honack, D.2
  • 81
    • 0011155298 scopus 로고    scopus 로고
    • Clinical experience with levetiracetam and zonisamide in children with uncontrolled epilepsy
    • Mandelbaum D.E., Kugler S.L., Wenger E.C., Wollack J.B., Venkat A. Clinical experience with levetiracetam and zonisamide in children with uncontrolled epilepsy. Epilepsia. 42 (Suppl. 7):2001;182.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 182
    • Mandelbaum, D.E.1    Kugler, S.L.2    Wenger, E.C.3    Wollack, J.B.4    Venkat, A.5
  • 82
    • 0032874698 scopus 로고    scopus 로고
    • Non-epileptic uses of gabapentin
    • Magnus L. Non-epileptic uses of gabapentin. Epilepsia. 40 (Suppl. 6):1999;S66-72.
    • (1999) Epilepsia , vol.40 , Issue.SUPPL. 6
    • Magnus, L.1
  • 83
    • 0011109028 scopus 로고    scopus 로고
    • Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in audiogenic susceptible mice
    • Matagne A.C., Baltes E., Coupez R., Patsalos P.N., Kiltgaard H.V. Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in audiogenic susceptible mice. Epilepsia. 42 (Suppl. 7):2001;82.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 82
    • Matagne, A.C.1    Baltes, E.2    Coupez, R.3    Patsalos, P.N.4    Kiltgaard, H.V.5
  • 84
    • 0011111202 scopus 로고    scopus 로고
    • Clinical experience with levetiracetam: Reported adverse events
    • abstract
    • Mateo C.I., Fix A.F., Jacobson M.P., French J.A. Clinical experience with levetiracetam: reported adverse events. Epilepsia. 42 (Suppl. 7):2001;257-258. (abstract).
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 257-258
    • Mateo, C.I.1    Fix, A.F.2    Jacobson, M.P.3    French, J.A.4
  • 85
    • 0035115746 scopus 로고    scopus 로고
    • The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects
    • Mathias S., Wetter T.C., Steiger A., Lancel M. The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects. Neurobiol. Aging. 22:2001;247-253.
    • (2001) Neurobiol. Aging , vol.22 , pp. 247-253
    • Mathias, S.1    Wetter, T.C.2    Steiger, A.3    Lancel, M.4
  • 86
    • 0011109029 scopus 로고    scopus 로고
    • A study of zonisamide (Zonegran®) in the formalin model of nociception
    • McCumber D., Chen K.S., Meyer K.B., Yaksh T.L. A study of zonisamide (Zonegran®) in the formalin model of nociception. J. Pain. 3 (Suppl. 1):2002;29.
    • (2002) J. Pain , vol.3 , Issue.SUPPL. 1 , pp. 29
    • McCumber, D.1    Chen, K.S.2    Meyer, K.B.3    Yaksh, T.L.4
  • 87
    • 0002355729 scopus 로고    scopus 로고
    • Cotherapy of lamotrigine/zonisamide results in significant elevation of zonisamide levels
    • abstract
    • McJilton J., DeToledo J., DeCerce J., et al. Cotherapy of lamotrigine/zonisamide results in significant elevation of zonisamide levels. Epilepsia. 37 (Suppl. 5):1996;173. (abstract).
    • (1996) Epilepsia , vol.37 , Issue.SUPPL. 5 , pp. 173
    • McJilton, J.1    DeToledo, J.2    DeCerce, J.3
  • 88
    • 0028269416 scopus 로고
    • Oxcarbazepine: Mechanisms of action
    • McLean M.J., Schmutz M., Wamil A.W., et al. Oxcarbazepine: mechanisms of action. Epilepsia. 35 (Suppl. 3):1994;S5-S9.
    • (1994) Epilepsia , vol.35 , Issue.SUPPL. 3
    • McLean, M.J.1    Schmutz, M.2    Wamil, A.W.3
  • 90
    • 0035656346 scopus 로고    scopus 로고
    • Zonisamide has beneficial effects on Parkinson's disease patients
    • Murata M., Horiuchi E., Kanazawa I. Zonisamide has beneficial effects on Parkinson's disease patients. Neurosci. Res. 41:2001b;397-399.
    • (2001) Neurosci. Res. , vol.41 , pp. 397-399
    • Murata, M.1    Horiuchi, E.2    Kanazawa, I.3
  • 92
    • 0011116211 scopus 로고    scopus 로고
    • Topiramate and valproate added to carbamazepine: Effect on objective measures of cognitive function in adults with epilepsy
    • Meador K.J., Hulihan J., Kamin M., Karim R. Topiramate and valproate added to carbamazepine: effect on objective measures of cognitive function in adults with epilepsy. Epilepsia. 42 (Suppl. 7):2001;251-252.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 251-252
    • Meador, K.J.1    Hulihan, J.2    Kamin, M.3    Karim, R.4
  • 93
    • 4243217018 scopus 로고    scopus 로고
    • Cross-sectional study comparing weight gain and androgen levels in women with epilepsy taking lamotrigine compared to valproate monotherapy
    • Morrell M.J., Isojarvi J.I.T., Gomez G.M.A., O'Neill F., Risner M. Cross-sectional study comparing weight gain and androgen levels in women with epilepsy taking lamotrigine compared to valproate monotherapy. Neurology. 56 (Suppl. 3):2001;A234.
    • (2001) Neurology , vol.56 , Issue.SUPPL. 3
    • Morrell, M.J.1    Isojarvi, J.I.T.2    Gomez, G.M.A.3    O'Neill, F.4    Risner, M.5
  • 94
    • 0034548387 scopus 로고    scopus 로고
    • Visual function in patients treated with the GABAergic anticonvulsant drug tiagabine
    • Nousiainen I., Mäntyjärvi M., Kälviäinen R. Visual function in patients treated with the GABAergic anticonvulsant drug tiagabine. Clin. Drug Invest. 20:2000;393-400.
    • (2000) Clin. Drug Invest. , vol.20 , pp. 393-400
    • Nousiainen, I.1    Mäntyjärvi, M.2    Kälviäinen, R.3
  • 95
    • 0035960666 scopus 로고    scopus 로고
    • No reversion in vigabatrin-associatred visual field-defects
    • Nousianen I., Maniyarvi M., Kalviainen R. No reversion in vigabatrin-associatred visual field-defects. Neurology. 57:2001;1916-1917.
    • (2001) Neurology , vol.57 , pp. 1916-1917
    • Nousianen, I.1    Maniyarvi, M.2    Kalviainen, R.3
  • 96
    • 0033621925 scopus 로고    scopus 로고
    • Pharmacokinetic profile of levetiracetam: Toward ideal characteristics
    • Patsalos P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol. Ther. 85:2000;77-85.
    • (2000) Pharmacol. Ther. , vol.85 , pp. 77-85
    • Patsalos, P.N.1
  • 97
    • 0035050092 scopus 로고    scopus 로고
    • Visual field function is stable in patients who continue long-term vigabatrin therapy: Implications for clinical decision making
    • Paul S.R., Krauss G.L., Miller N.R., Medura M.T., Miller T.A., Johnson M.A. Visual field function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making. Epilepsia. 42:2001;525-530.
    • (2001) Epilepsia , vol.42 , pp. 525-530
    • Paul, S.R.1    Krauss, G.L.2    Miller, N.R.3    Medura, M.T.4    Miller, T.A.5    Johnson, M.A.6
  • 99
    • 0011139866 scopus 로고    scopus 로고
    • Lamotrigine decreases the excitability of dendrites in hippocampal pyramidal neurons by increasing activation of Ih
    • Poolos N.P., Johnston D. Lamotrigine decreases the excitability of dendrites in hippocampal pyramidal neurons by increasing activation of Ih. Epilepsia. 42 (Suppl. 7):2001;82-83.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 82-83
    • Poolos, N.P.1    Johnston, D.2
  • 100
    • 0001852047 scopus 로고    scopus 로고
    • Topiramate vs. investigator choice of carbamazepine or valproate as monotherapy in newly diagnosed epilepsy
    • Privitera M.D., Brodie M.J., Neto W., Wang S. Topiramate vs. investigator choice of carbamazepine or valproate as monotherapy in newly diagnosed epilepsy. Epilepsia. 41 (Suppl. 7):2001;93.
    • (2001) Epilepsia , vol.41 , Issue.SUPPL. 7 , pp. 93
    • Privitera, M.D.1    Brodie, M.J.2    Neto, W.3    Wang, S.4
  • 101
    • 0026447816 scopus 로고
    • Comparison of the effect GABA uptake inhibitor blockers, tiagabine and nipecotic acid, on inhibitory synaptic efficacy in hippocampal CA1 neurones
    • Roepstorff A., Lambert J.D.C. Comparison of the effect GABA uptake inhibitor blockers, tiagabine and nipecotic acid, on inhibitory synaptic efficacy in hippocampal CA1 neurones. Neurosci. Lett. 146:1992;131-134.
    • (1992) Neurosci. Lett. , vol.146 , pp. 131-134
    • Roepstorff, A.1    Lambert, J.D.C.2
  • 103
  • 104
    • 0033794821 scopus 로고    scopus 로고
    • A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy
    • Ring H.A., White S., Costa D.C., et al. A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy. Seizure. 9:2000;380-384.
    • (2000) Seizure , vol.9 , pp. 380-384
    • Ring, H.A.1    White, S.2    Costa, D.C.3
  • 105
    • 0000548303 scopus 로고    scopus 로고
    • Pregabalin shows anticonvulsant activity onset by second day
    • Robbins J.L., Kugler A.R., Anhut H., Smith T.M., Garofalo E.A. Pregabalin shows anticonvulsant activity onset by second day. Epilepsia. 42 (Suppl. 7):2001;211.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 211
    • Robbins, J.L.1    Kugler, A.R.2    Anhut, H.3    Smith, T.M.4    Garofalo, E.A.5
  • 107
    • 0034677733 scopus 로고    scopus 로고
    • The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits
    • Rundfeldt C., Netzer R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits. Neurosci. Lett. 281:2000;73-76.
    • (2000) Neurosci. Lett. , vol.281 , pp. 73-76
    • Rundfeldt, C.1    Netzer, R.2
  • 108
    • 0033961645 scopus 로고    scopus 로고
    • Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study
    • Rush A.J., George M.S., Sackeim H.A., et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol. Psychiatry. 47:2000;276-286.
    • (2000) Biol. Psychiatry , vol.47 , pp. 276-286
    • Rush, A.J.1    George, M.S.2    Sackeim, H.A.3
  • 109
    • 0001051787 scopus 로고    scopus 로고
    • Safety and efficacy of oxcarbazepine 1200 mg/day in patients with recent-onset partial epilepsy
    • abstract
    • Sachdeo R., Edwards K., Hasegawa H., et al. Safety and efficacy of oxcarbazepine 1200 mg/day in patients with recent-onset partial epilepsy. Neurology. 52 (Suppl. 2):1999;A391. (abstract).
    • (1999) Neurology , vol.52 , Issue.SUPPL. 2
    • Sachdeo, R.1    Edwards, K.2    Hasegawa, H.3
  • 110
    • 0035845665 scopus 로고    scopus 로고
    • Oxcarbazepine (trileptal) as monotherapy in patients with partial seizures
    • Sachdeo R., Beydoun A., Schachter S.C., et al. Oxcarbazepine (trileptal) as monotherapy in patients with partial seizures. Neurology. 57:2001;864-871.
    • (2001) Neurology , vol.57 , pp. 864-871
    • Sachdeo, R.1    Beydoun, A.2    Schachter, S.C.3
  • 111
    • 0036225533 scopus 로고    scopus 로고
    • Effects of oxcarbazepine on sodium concentrations and water handling
    • Sachdeo R., Wasserstein A., Mesenbrink P., D'Souza J. Effects of oxcarbazepine on sodium concentrations and water handling. Ann. Neurol. 51:2002;613-620.
    • (2002) Ann. Neurol. , vol.51 , pp. 613-620
    • Sachdeo, R.1    Wasserstein, A.2    Mesenbrink, P.3    D'Souza, J.4
  • 113
    • 0033541097 scopus 로고    scopus 로고
    • Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures
    • Schachter S.C., Vazquez B., Fisher R.S., et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology. 52:1999;732-737.
    • (1999) Neurology , vol.52 , pp. 732-737
    • Schachter, S.C.1    Vazquez, B.2    Fisher, R.S.3
  • 117
    • 0032702948 scopus 로고    scopus 로고
    • Vigabatrin and tiagabine are pharmacologically different drugs. A preclinical study
    • Sills G.J., Butler E., Thompson G.G., Brodie M. Vigabatrin and tiagabine are pharmacologically different drugs. A preclinical study. Seizure. 8:1999;404-411.
    • (1999) Seizure , vol.8 , pp. 404-411
    • Sills, G.J.1    Butler, E.2    Thompson, G.G.3    Brodie, M.4
  • 118
    • 0035943079 scopus 로고    scopus 로고
    • Visual field constriction: Accumulation of vigabatrin but not tiagabine in the retina
    • Sills G.J., Patsalos P.N., Butler E., Forrest G., Ratnaraj N., Brodie M. Visual field constriction: Accumulation of vigabatrin but not tiagabine in the retina. Neurolgy. 57:2001;196-200.
    • (2001) Neurolgy , vol.57 , pp. 196-200
    • Sills, G.J.1    Patsalos, P.N.2    Butler, E.3    Forrest, G.4    Ratnaraj, N.5    Brodie, M.6
  • 119
    • 0011106894 scopus 로고    scopus 로고
    • A receptors expressed in Xenopus oocytes
    • A receptors expressed in Xenopus oocytes. Epilepsia. 42 (Suppl. 7):2001;14.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 14
    • Simeone, T.A.1    White, H.S.2
  • 120
    • 0033963231 scopus 로고    scopus 로고
    • Autoimmune encephalomyelitis ameliorated by AMPA antagonists
    • Smith T., Groom A., Zhu B., Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat. Med. 6:2000;62-66.
    • (2000) Nat. Med. , vol.6 , pp. 62-66
    • Smith, T.1    Groom, A.2    Zhu, B.3    Turski, L.4
  • 121
    • 0032890766 scopus 로고    scopus 로고
    • Structure-pharmacokinetic-pharmacodynamic relationships of the new antiepileptic drug valproyl glycinamide
    • Spiegelstein O., Yagen B., Bialer M. Structure-pharmacokinetic-pharmacodynamic relationships of the new antiepileptic drug valproyl glycinamide. Epilepsia. 40:1999;545-552.
    • (1999) Epilepsia , vol.40 , pp. 545-552
    • Spiegelstein, O.1    Yagen, B.2    Bialer, M.3
  • 122
    • 0029082313 scopus 로고
    • Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents
    • Stefani A., Pisani A., De Murtas M., et al. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Epilepsia. 36:1995;997-1002.
    • (1995) Epilepsia , vol.36 , pp. 997-1002
    • Stefani, A.1    Pisani, A.2    De Murtas, M.3
  • 123
    • 0011079578 scopus 로고    scopus 로고
    • Tiagabine adjunctive therapy: An observational study
    • The Epilepsy Observational Investigation Group of Spain, Salas-Puig J., Arroyo S. Tiagabine adjunctive therapy: an observational study. Epilepsia (Florence). 41:2000;40.
    • (2000) Epilepsia (Florence) , vol.41 , pp. 40
    • Salas-Puig, J.1    Arroyo, S.2
  • 124
    • 0033811027 scopus 로고    scopus 로고
    • Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures
    • The European Levetiracetam Study Group, Shorvon S.D., Lowenthal A., Janz D., Bielen E., Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia. 41:2000;1179-1186.
    • (2000) Epilepsia , vol.41 , pp. 1179-1186
    • Shorvon, S.D.1    Lowenthal, A.2    Janz, D.3    Bielen, E.4    Loiseau, P.5
  • 125
    • 0031775386 scopus 로고    scopus 로고
    • A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures
    • The International Gabapentin Monotherapy Study Group 945-77, Chadwick D.W., Anhut H., Greiner M.J., Alexander J., Murray G.H., Garofalo E.A., Pierce M.W. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology. 51:1998;1282-1288.
    • (1998) Neurology , vol.51 , pp. 1282-1288
    • Chadwick, D.W.1    Anhut, H.2    Greiner, M.J.3    Alexander, J.4    Murray, G.H.5    Garofalo, E.A.6    Pierce, M.W.7
  • 126
    • 0011083220 scopus 로고    scopus 로고
    • Open multicentre study of tiagabine as add on treatment in patients with partial seizures
    • The Study Group, Czapinski P., Jedrzejczak J., Kozik A., Wendorff J., Sobaniec W., Grygolec P. Open multicentre study of tiagabine as add on treatment in patients with partial seizures. Epilepsia. 41 (Suppl. 6):2000;40.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL. 6 , pp. 40
    • Czapinski, P.1    Jedrzejczak, J.2    Kozik, A.3    Wendorff, J.4    Sobaniec, W.5    Grygolec, P.6
  • 127
    • 0033854805 scopus 로고    scopus 로고
    • Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
    • The United States Levetiracetam Study Group, Cereghino J.J., Biton V., Abou-Khali B., Dreifuss F., Gauer L.J., Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology. 55:2000;236-242.
    • (2000) Neurology , vol.55 , pp. 236-242
    • Cereghino, J.J.1    Biton, V.2    Abou-Khali, B.3    Dreifuss, F.4    Gauer, L.J.5    Leppik, I.6
  • 128
    • 0038465037 scopus 로고    scopus 로고
    • Extended-release vs. enteric-coated formulations of divalproex sodium: Results of a randomized, crossover study of epileptic patients with primary generalized seizures
    • Quebec, July
    • Thibault, M., Blume, W., St. Hilaire, J., Zakhari, R., Sommerville, K.W., 2001. Extended-release vs. enteric-coated formulations of divalproex sodium: Results of a randomized, crossover study of epileptic patients with primary generalized seizures. Focus on Epilepsy, Quebec, July.
    • (2001) Focus on Epilepsy
    • Thibault, M.1    Blume, W.2    St. Hilaire, J.3    Zakhari, R.4    Sommerville, K.W.5
  • 129
    • 0029891002 scopus 로고    scopus 로고
    • D-23129: A potent anticonvulsant in the amygdala kindling model of complex partial seizures
    • Tober C., Rostock A., Rundfeldt C., Bartsch R. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur. J. Pharmacol. 303:1996;163-169.
    • (1996) Eur. J. Pharmacol. , vol.303 , pp. 163-169
    • Tober, C.1    Rostock, A.2    Rundfeldt, C.3    Bartsch, R.4
  • 133
    • 0032762648 scopus 로고    scopus 로고
    • Characteristics of a unique visual field defect attributed to vigabatrin
    • Wild J.M., Martinez C., Reinshagen G., Harding G.F. Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia. 40:1999;1784-1794.
    • (1999) Epilepsia , vol.40 , pp. 1784-1794
    • Wild, J.M.1    Martinez, C.2    Reinshagen, G.3    Harding, G.F.4
  • 135
    • 0031962477 scopus 로고    scopus 로고
    • High dose gabapentin in refractory partial epilepsy: Clinical observations in 50 patients
    • Wilson E.A., Sills G.J., Forrest G., Brodie M.J. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients. Epilepsy Res. 29:1998;161-166.
    • (1998) Epilepsy Res. , vol.29 , pp. 161-166
    • Wilson, E.A.1    Sills, G.J.2    Forrest, G.3    Brodie, M.J.4
  • 136
    • 0033755854 scopus 로고    scopus 로고
    • Slow hyperpolarization in cortical neurons: A possible mechanism behind vagus nerve simulation therapy for refractory epilepsy?
    • Zagon A., Kemeny A.A. Slow hyperpolarization in cortical neurons: a possible mechanism behind vagus nerve simulation therapy for refractory epilepsy? Epilepsia. 41:2000;1382-1389.
    • (2000) Epilepsia , vol.41 , pp. 1382-1389
    • Zagon, A.1    Kemeny, A.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.